Thermosensitive Alginate/Carrageenan–Stearic Acid Dissolving Microneedles Incorporating Liposome-Coated Hollow Mesoporous Silica Nanoparticles for Controlled Caffeine Delivery

Information from the abstract

Caffeine is a promising active for topical pharmaceutical and cosmetic applications; however, its hydrophilic nature can limit passive transport across the stratum corneum and reduce local retention. Although nanoparticle-loaded dissolving microneedles have been explored, few systems combine a hollow porous carrier, a lipid coating, and a polysaccharide matrix within a single controlled-release platform. This study developed thermosensitive dissolving microneedles (DMNs) incorporating caffeine-loaded liposome-coated hollow mesoporous silica nanoparticles (ULp-Caf@HMSNs). Sodium alginate–κ-carrageenan matrices, with and without stearic acid modification, were evaluated for their effects on thermal behavior, mechanical strength, and caffeine release. HMSNs showed a hollow mesoporous structure and high specific surface area, while FTIR supported successful incorporation of the formulation components. Liposome coating increased particle size while maintaining nanoscale dimensions. Hot-stage microscopy showed temperature-dependent structural changes at approximately 33–35 °C, with lower apparent transition temperatures in stearic acid-containing formulations. All DMNs exhibited compression forces comparable to mechanically competent DMNs, with NaAlg–κ-car systems reaching 14.3–15.1 N per array. Free-caffeine DMNs followed non-Fickian release, whereas ULp-Caf@HMSN-containing formulations followed Higuchi diffusion-controlled release and showed slower caffeine release. Stearic acid did not consistently improve release performance. The novelty of this work lies in integrating a hollow silica reservoir, a liposomal coating, and an alginate–κ-carrageenan microneedle matrix within one platform. Overall, the system provides a basis for further evaluation in controlled topical or transdermal caffeine delivery.

Why this record is monitored

This record has an Impact Signal of 71/100 based on recency, source, collaboration, and bibliographic signals. It prioritizes monitoring and is not a judgment of research quality.

Related topics: Advancements in Transdermal Drug Delivery · Advanced Drug Delivery Systems · Ocular Surface and Contact Lens